TY - JOUR
T1 - Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis
AU - Kawada, Jun Ichi
AU - Yamaguchi, Makoto
AU - Haruta, Kazunori
AU - Fukuda, Yuto
AU - Iwata, Ken Ichi
AU - Suzuki, Takako
AU - Torii, Yuka
N1 - Publisher Copyright:
© 2025 Oxford University Press. All rights reserved.
PY - 2025/3/1
Y1 - 2025/3/1
N2 - Objectives: Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis. Methods: Proteomic profiling of the sera collected from 11 patients with CRMO (5 patients were in active phase, 6 were in inactive phase) was conducted using liquid chromatography–mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO. Results: Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients. Conclusion: Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.
AB - Objectives: Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis. Methods: Proteomic profiling of the sera collected from 11 patients with CRMO (5 patients were in active phase, 6 were in inactive phase) was conducted using liquid chromatography–mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO. Results: Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients. Conclusion: Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.
KW - chronic recurrent multifocal osteomyelitis
KW - proteomic profiles
KW - serum
UR - http://www.scopus.com/inward/record.url?scp=86000172643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=86000172643&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/keae301
DO - 10.1093/rheumatology/keae301
M3 - Article
C2 - 38775453
AN - SCOPUS:86000172643
SN - 1462-0324
VL - 64
SP - 1138
EP - 1146
JO - Rheumatology
JF - Rheumatology
IS - 3
ER -